Varian Medical Systems, Inc. (VAR)

NYSE - NYSE Real Time Price. Currency in USD
98.54-1.01 (-1.01%)
At close: 4:02 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close99.55
Bid98.56 x 300
Ask98.57 x 400
Day's Range97.85 - 99.49
52wk Range72.74 - 99.66
1y Target EstN/A
Market Cap9.2B
P/E Ratio (ttm)25.01
Avg Vol (3m)649,865
Dividend & Yield0.00 (0.00%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Varian (VAR) Launches Software Platform for Cancer Care
    Zacks2 days ago

    Varian (VAR) Launches Software Platform for Cancer Care

    Varian Medical Systems Inc. (VAR) recently launched the 360 Oncology care management platform.

  • PR Newswire4 days ago

    Varian Exhibiting New HyperArc Technology for High Definition Radiotherapy and Radiosurgery

    Varian is exhibiting its new HyperArc™ High Definition Radiotherapy (HDRT) technology at the 2016 American Society for Radiation Oncology (ASTRO) Annual Meeting. "This exciting new technology unlocks the potential of using highly non-coplanar treatment strategies to usher in a new era of precision in radiotherapy and radiosurgery for cancer patients," said Kolleen Kennedy, president of Varian Oncology Systems.

  • PR Newswire4 days ago

    Varian Unveils First Comprehensive Software Platform for Coordinating Cancer Care in Health Systems

    PALO ALTO, Calif., Sept. 26, 2016 /PRNewswire/ -- Varian Medical Systems (VAR) today announced the 360 Oncology™ care management platform, the first software system designed to integrate and coordinate key elements of cancer care so patients and their cancer teams can collaborate on achieving the best outcomes. 360 Oncology brings together in a single platform, radiation, medical and surgical oncology, social services, primary care physicians, as well as the patient, to facilitate true collaborative and coordinated care. "Until today, cancer care teams were challenged in trying to pull together all the relevant health information across disparate systems and specialists to make the best decisions regarding care," said Kolleen Kennedy, president of Varian's Oncology Systems business.